Literature DB >> 32927464

Predicting change in diagnosis from major depression to bipolar disorder after antidepressant initiation.

Melanie F Pradier1, Michael C Hughes2, Thomas H McCoy3,4, Sergio A Barroilhet3,4,5,6, Finale Doshi-Velez7, Roy H Perlis8,9.   

Abstract

We aimed to develop and validate classification models able to identify individuals at high risk for transition from a diagnosis of depressive disorder to one of bipolar disorder. This retrospective health records cohort study applied outpatient clinical data from psychiatry and nonpsychiatry practice networks affiliated with two large academic medical centers between March 2008 and December 2017. Participants included 67,807 individuals with a diagnosis of major depressive disorder or depressive disorder not otherwise specified and no prior diagnosis of bipolar disorder, who received at least one of the nine antidepressant medications. The main outcome was at least one diagnostic code reflective of a bipolar disorder diagnosis within 3 months of index antidepressant prescription. Logistic regression and random forests using diagnostic and procedure codes as well as sociodemographic features were used to predict this outcome, with discrimination and calibration assessed in a held-out test set and then a second academic medical center. Among 67,807 individuals who received at least one antidepressant medication, 925 (1.36%) subsequently received a diagnosis of bipolar disorder within 3 months. Models incorporating coded diagnoses and procedures yielded a mean area under the receiver operating characteristic curve of 0.76 (ranging from 0.73 to 0.80). Standard supervised machine learning methods enabled development of discriminative and transferable models to predict transition to bipolar disorder. With further validation, these scores may enable physicians to more precisely calibrate follow-up intensity for high-risk patients after antidepressant initiation.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32927464      PMCID: PMC7852537          DOI: 10.1038/s41386-020-00838-x

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  1 in total

1.  Antidepressant-resistant depression and antidepressant-associated suicidal behaviour: the role of underlying bipolarity.

Authors:  Zoltan Rihmer; Xenia Gonda
Journal:  Depress Res Treat       Date:  2011-04-03
  1 in total
  2 in total

1.  Real-world evidence of age-independent electroconvulsive therapy efficacy: A retrospective cohort study.

Authors:  James Luccarelli; Thomas H McCoy; Stephen J Seiner; Michael E Henry
Journal:  Acta Psychiatr Scand       Date:  2021-10-25       Impact factor: 6.392

2.  Alterations of Plasma Lipids in Adult Women With Major Depressive Disorder and Bipolar Depression.

Authors:  Ting Zhang; Lin Guo; Rui Li; Fei Wang; Wen-Mao Yang; Jia-Bin Yang; Zhi-Quan Cui; Cui-Hong Zhou; Yi-Huan Chen; Huan Yu; Zheng-Wu Peng; Qing-Rong Tan
Journal:  Front Psychiatry       Date:  2022-07-18       Impact factor: 5.435

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.